search
Back to results

Oxycodone vs. Fentanyl in Early Postoperative Pain After Total Hip Replacement

Primary Purpose

Pain, Postoperative

Status
Unknown status
Phase
Phase 4
Locations
Korea, Republic of
Study Type
Interventional
Intervention
Oxycodone
Fentanyl
Sponsored by
Kyunghee University Medical Center
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional treatment trial for Pain, Postoperative focused on measuring postoperative pain

Eligibility Criteria

19 Years - 65 Years (Adult, Older Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria:

  • 19-65 years of age
  • ASA physical status classification I or II
  • Scheduled for total hip replacement surgery

Exclusion Criteria:

  • Allergic to study drugs
  • Patient with asthma or COPD, patient who is severely respiratory depressed
  • Renal of hepatic insufficiency
  • Epileptic status
  • Intracranial lesion associated with increased intracranial pressure
  • Acute abdomen, patient who has diagnosed paralytic ileus or suspicious ileus
  • Pregnant or lactating women

Sites / Locations

  • Kyung Hee University HospitalRecruiting

Arms of the Study

Arm 1

Arm 2

Arm Type

Experimental

Active Comparator

Arm Label

Oxycodone

Fentanyl

Arm Description

4mg of oxycodone iv bolus

50ug of fentanyl iv bolus

Outcomes

Primary Outcome Measures

Postoperative pain measurement using Numeric Rating Scale(NRS)
Measure postoperative pain using NRS at the PostAnesthesia Care Unit(PACU)

Secondary Outcome Measures

Additional doses of fentanyl for pain management
0-6 hours, 6-12 hours, 12-24 hours, 24-48 hours after surgery

Full Information

First Posted
January 11, 2017
Last Updated
January 11, 2017
Sponsor
Kyunghee University Medical Center
search

1. Study Identification

Unique Protocol Identification Number
NCT03019562
Brief Title
Oxycodone vs. Fentanyl in Early Postoperative Pain After Total Hip Replacement
Official Title
Oxycodone vs. Fentanyl in the Treatment of Early Postoperative Pain After Total Hip Replacement
Study Type
Interventional

2. Study Status

Record Verification Date
January 2017
Overall Recruitment Status
Unknown status
Study Start Date
December 2016 (undefined)
Primary Completion Date
December 2017 (Anticipated)
Study Completion Date
December 2017 (Anticipated)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
Kyunghee University Medical Center

4. Oversight

Data Monitoring Committee
Yes

5. Study Description

Brief Summary
Oxycodone is one of the most widely used opioids for pain treatment. Many studies demonstrated good efficacy of oxycodone on postoperative pain. In this study, we assess the efficacy and side effects of bolus intravenous of oxycodone injection compared to those of fentanyl in patients after total hip replacement surgery.
Detailed Description
Oxycodone is one of the most widely used opioids for pain treatment. There have been several studies on the efficacy and side effects of oxycodone. Oxycodone has been known to have the same potency with morphine. Many studies demonstrated good efficacy of oxycodone on postoperative pain. In this study, we designed a prospective, randomized, and double-blind study to assess the efficacy and side effects of bolus intravenous of oxycodone injection compared to those of fentanyl in patients who underwent the total hip replacement surgery.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Pain, Postoperative
Keywords
postoperative pain

7. Study Design

Primary Purpose
Treatment
Study Phase
Phase 4
Interventional Study Model
Parallel Assignment
Masking
ParticipantInvestigatorOutcomes Assessor
Allocation
Randomized
Enrollment
46 (Anticipated)

8. Arms, Groups, and Interventions

Arm Title
Oxycodone
Arm Type
Experimental
Arm Description
4mg of oxycodone iv bolus
Arm Title
Fentanyl
Arm Type
Active Comparator
Arm Description
50ug of fentanyl iv bolus
Intervention Type
Drug
Intervention Name(s)
Oxycodone
Other Intervention Name(s)
Oxynorm
Intervention Description
4mg of oxycodone iv 20 min before the end of surgery, 10ug/kg of fentanyl in Patient-Controlled Analgesia(PCA)
Intervention Type
Drug
Intervention Name(s)
Fentanyl
Intervention Description
50ug of fentanyl iv 20 min before the end of surgery, 10ug/kg of fentanyl in Patient-Controlled Analgesia(PCA),
Primary Outcome Measure Information:
Title
Postoperative pain measurement using Numeric Rating Scale(NRS)
Description
Measure postoperative pain using NRS at the PostAnesthesia Care Unit(PACU)
Time Frame
Immediately after surgery
Secondary Outcome Measure Information:
Title
Additional doses of fentanyl for pain management
Description
0-6 hours, 6-12 hours, 12-24 hours, 24-48 hours after surgery
Time Frame
From immediately after surgery to 2 days after surgery
Other Pre-specified Outcome Measures:
Title
Adverse effect
Time Frame
From immediately after surgery to 2 days after surgery

10. Eligibility

Sex
All
Minimum Age & Unit of Time
19 Years
Maximum Age & Unit of Time
65 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: 19-65 years of age ASA physical status classification I or II Scheduled for total hip replacement surgery Exclusion Criteria: Allergic to study drugs Patient with asthma or COPD, patient who is severely respiratory depressed Renal of hepatic insufficiency Epileptic status Intracranial lesion associated with increased intracranial pressure Acute abdomen, patient who has diagnosed paralytic ileus or suspicious ileus Pregnant or lactating women
Central Contact Person:
First Name & Middle Initial & Last Name or Official Title & Degree
Youngsoon Kim, MD, PhD
Phone
+82-2-958-8598
Email
ys.kim@khu.ac.kr
First Name & Middle Initial & Last Name or Official Title & Degree
Hee Yong Kang, MD
Phone
+82-2-958-8589
Email
ujuabba@gmail.com
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Mi Kyeong Kim, MD, PhD
Organizational Affiliation
Kyunghee University Medical Center
Official's Role
Principal Investigator
Facility Information:
Facility Name
Kyung Hee University Hospital
City
Seoul
ZIP/Postal Code
02447
Country
Korea, Republic of
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Youngsoon Kim
Phone
958-8589
Email
ys.kim@khu.ac.kr

12. IPD Sharing Statement

Plan to Share IPD
No

Learn more about this trial

Oxycodone vs. Fentanyl in Early Postoperative Pain After Total Hip Replacement

We'll reach out to this number within 24 hrs